Article
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.
Hepatology (Baltimore, Md.) - 1 Dec 2020
Degasperi Elisabetta, Galmozzi Enrico, Pelusi Serena, D'Ambrosio Roberta, Soffredini Roberta, Borghi Marta, Perbellini Riccardo, Facchetti Floriana, Iavarone Massimo, Sangiovanni Angelo, Valenti Luca, Lampertico Pietro
Abstract excerpt
BACKGROUND AND AIMS: Genetic factors and steatosis predispose to hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus; however, their impact in patients with cirrhosis cured by direct-acting antivirals (DAAs) is still undefined. We assessed the association between a genetic risk score (GRS) of hepatic fat accumulation, combining variants in PNPLA3 (patatin-like phospholipase domain containing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
